Insomnia: Therapeutic Approach

Southern Medical Journal

Volumn 94, Issue 9, 2001, Pages 866-873

  Lippmann, Steven ^a,b   Mazour, Iourii ^a   Shahab, Hasan ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INSOMNIA; REVIEW;

HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 0035458699     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200194090-00007     Document Type: Article

References (63)

1. Gillin JC: Relief from situational insomnia: pharmacologic and other options. Postgrad Med 1992; 92:157-160
2. The Gallup Organization: Sleep in America: A National Survey of U.S. Adults. Washington, DC National Sleep Foundation, 1995
3. Hajak G, Bandelow B: Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16,944 cases. Int Clin Psychopharmacol 1998; 13:157-167
4. Radecki SE, Brunton SA: Management of insomnia in office-based practice: national prevalence and therapeutic patterns. Arch Fam Med 1993; 2:1129-1134
5. Gillin JC, Byerley WF: The diagnosis and management of insomnia. N Engl J Med 1990; 322:239-248
6. Roehrs T, Zorick F, Roth T: Transient and short-term insomnia. Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC (eds). Philadelphia, WB Saunders Co, 2nd Ed, 1994, pp 486-493
7. Hauri PJ: Insomnia. Clin Chest Med 1998; 19:157-168
8. Drugs and insomnia: the use of medications to promote sleep. JAMA 1984; 251:2410-2414
9. Walsh JK, Fillingim JM: Role of hypnotic drugs in general practice. Am J Med 1990; 88:345-385
10. Bootzin RR, Perlis ML: Nonpharmacologic treatments of insomnia. J Clin Psychiatry 1992; 53:37-41
11. Buysse DJ, Reynolds CF III: Insomnia. Handbook of Sleep Disorders. Thorpy MJ (ed). New York, Marcel Dekker Inc, 1990, pp 375-432
12. Dinner DS, Erman MK, Roth T: Help for geriatric sleep problems. Patient Care 1992; 26:166-187
13. Cooper R: The classification of sleep disorders. Sleep. Cooper R (ed). London, Chapman and Hall, 1994, p 269
14. Hartmann PM: Drug treatment of insomnia: indications and newer agents. Am Fam Physician 1995; 51:191-194
15. Becker PM, Jamieson AO, Brown WD: Insomnia: use of a 'decision tree' to assess and treat. Postgrad Med 1993; 93:66-85
16. Ancoli-Israel S: All I Want Is a Good Night's Sleep. St. Louis, Mosby-Year Book Inc, 1996, p 116
17. Brunton SA: When your patient can't sleep. Fam Prac Recertif 1992; 14:149-170
18. Rakel RE: Insomnia: concerns of the family physician. J Fam Pract 1993; 36:551-558
19. Ball EM: Sleep disorders in primary care. Comp Ther 1997; 23:25-30
20. Pary R, Tobias CR, Webb WK, et al: Treatment of insomnia: getting to the root of sleeping problems. Postgrad Med 1996; 100:195-210
21. Mosier WA, Nelson AS, Walgren KD: Wanted: a good night's sleep. Adv Nurse Pract 1998; 6:30-35.
22. Nakra BRS, Grossberg GT, Peck B: Insomnia in the elderly. Am Fam Physician 1991; 43:477-483
23. Regestein QR: Treatment of insomnia in the elderly. Clinical Geriatric Psychopharmacology. Salzman C (ed). New York, McGraw Hill, 1984, pp 149-170
24. Roth T, Roehrs TA: A review of the safety profiles of benzodiazepine hypnotics. J Clin Psychiatry 1991; 52(suppl 9):38-41
25. Wagner J, Wagner ML, Hening W: Beyond benzodiazepines: alternative pharmacological agents for the treatment of insomnia. Ann Pharmacother 1998; 32:680-691
26. Gillin JC, Ancoli-Israel S, Erman M: Sleep and sleep-wake disorders. Psychiatry. Tasman A, Kay J, Lieberman JA (eds). Philadelphia, WB Saunders Co, 2nd Ed, 1996, pp 1217-1248
27. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989; 262:1479-1484
28. Eaton WE, Badawi M, Melton B: Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry 1995; 152:967-972
29. Keck PE: Insomnia in anxiety and depression: differential diagnosis and treatment options. Modern Med 1992; 60:79-86
30. Lahmeyer HW: Insomnia: how to help patients get a good night's sleep. Consultant 1995, pp 108-111
31. Czeisler CA, Johnson MP, Duffy JF, et al: Exposure to bright light and darkness to treat physiologic maladaption to night work. NEngJMed 1990; 322:1253-1259
32. Guilleminault C, Clerk A, Black J. et al: Nondrug treatment trials in psychophysiologic insomnia. Arch Intern Med 1995; 55:838-844
33. Dingemanse J: Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci 1995; 17:67-75
34. Kupfer DJ, Reynolds CF III: Management of insomnia. N Engl J Med 1997; 336:341-346
35. Tsoi WF: Insomnia: drug treatment. Ann Acad Med 1991; 20:269-272
36. Parrino L, Terzano MG: Polysomnographic effects of hypnotic drugs: a review. Psychopharmacol 1996; 126:1-16
37. Physicians' Desk Reference. Montvale, NJ, Medical Economics Co, 1999
38. Hoehns JD, Perry PJ: Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993; 12:814-828
39. Heel RC, Brogden RN, Speight TM, et al: Temazepam: a review of its pharmacological properties and therapeutic efficacy as a hypnotic, Drugs 1981; 21:321-340
40. Wheatley D: Prescribing short-acting hypnosedatives: current recommendations from a safety perspective. Drug Safety 1992; 7:106-115
41. Morin CM, Kwentus JA: Behavioral and pharmacological treatments for insomnia. Ann Behav Med 1988; 10:91-100
42. Mendelson WB, Jain B: An assessment of short-acting hypnotics. Drug Safety 1995; 13:257-270
43. Zolpidem - a hypnotic with a difference? Drug Ther Bull 1995; 33:37-39
44. Dockhorn RJ, Dockhorn DW: Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial. Clin Neuropharmacol 1996; 19:333-340
45. Monti JM, Attali P, Monti D, et al: Zolpidem and rebound insomnia - a double blind, controlled, polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994; 27:166-175
46. Monti JM, Monti D, Estévez F, et al: Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. Int Clin Psychopharmacol 1996; 11:255-263
47. Roth T, Roehrs T, Vogel G: Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 1995; 18:246-251
48. Maarrek L, Cramer P, Attali P, et al: The safety and efficacy of zolpidem in insomniac patients: a long-term study in general practice. J Int Med Res 1992; 20:162-170
49. Scharf MB, Roth T, Vogel GW, et al: A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994; 55:192-199
50. Allain H, Monti J: General safety profile of zolpidem: safety in elderly, overdose and rebound effects. Eur Psychiatry 1997; 12(suppll):21S-29S
51. Besset A, Tafti M, Villemin E, et al: Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepers. Drugs Exp Clin Res 1995; 21:161-169
52. Beer B, Ieni J, Wu WH, et al: A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic. J Clin Pharmacol 1994; 34:335-344
53. Sakamoto T, Uchimura N, Mukai M, et al: Efficacy of L-846 in patients with insomnia: evaluation by polysomnography. Psychiatr Clin Neurosci 1998; 52:156-157
54. Elie R, Ruther E, Farr I, et al: Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. J Clin Psychiatry 1999; 60:536-544
55. Walsh JK, Fry J, Erwin CW, et al: Efficacy and tolerability of 14-day administration of zaleplon 5 mg and 10 mg for the treatment of primary insomnia. Clin Drug Invest 1998; 16:347-354
56. Roth T, Roehrs TA, Fortier J, et al: Dose response effects of a new hypnotic in insomniacs. Sleep Res 1995; 24:53
57. Sonata (zaleplon) prescribing information. Wyeth-Ayerst Laboratories, 1999
58. Sharpley AL, Cowen PJ: Effect of pharmacological treatments on the sleep of depressed patients. Biol Psychiatry 1995; 37:85-98
59. Winokur A, Reynolds CF: The effects of antidepressants on sleep physiology. Prim Psychiatry 1994; 1:22-27
60. McElroy SL, Keck PE, Friedman LM: Minimizing and managing antidepressant side effects. J Clin Psychiatry 1995; 56:49-55
61. McEvoy GK (ed). Antihistamine drugs. AHFS Drug Information 95. Bethesda, American Society of Hospital Pharmacists, 1995
62. Crismon ML, Jermain DM: Sleep aid and stimulant products. Handbook of Non-prescription Drugs, 10th Ed, 1996, pp 135-146
63. Chessor A: Practice parameters for the evaluation of chronic insomnias. Sleep 2000; 22:237-241